U.S. markets close in 20 minutes
  • S&P 500

    4,591.89
    +53.46 (+1.18%)
     
  • Dow 30

    35,222.17
    +642.09 (+1.86%)
     
  • Nasdaq

    15,228.99
    +143.52 (+0.95%)
     
  • Russell 2000

    2,209.48
    +50.18 (+2.32%)
     
  • Crude Oil

    69.63
    +3.37 (+5.09%)
     
  • Gold

    1,780.00
    -3.90 (-0.22%)
     
  • Silver

    22.36
    -0.12 (-0.52%)
     
  • EUR/USD

    1.1284
    -0.0033 (-0.29%)
     
  • 10-Yr Bond

    1.4340
    +0.0910 (+6.78%)
     
  • GBP/USD

    1.3258
    +0.0023 (+0.17%)
     
  • USD/JPY

    113.4520
    +0.6520 (+0.58%)
     
  • BTC-USD

    49,167.50
    +346.98 (+0.71%)
     
  • CMC Crypto 200

    1,270.76
    +10.60 (+0.84%)
     
  • FTSE 100

    7,232.28
    +109.96 (+1.54%)
     
  • Nikkei 225

    27,927.37
    -102.20 (-0.36%)
     

Company News for Oct 11, 2021

·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Share of Accolade, Inc. ACCD gained 4.3% after the company reported second quarter fiscal 2021 loss of $0.43 per share, lower than the Zacks Consensus Estimate of a loss of $0.45.

  • ChemoCentryx, Inc.’s CCXI shares surged 96% after the company announced that the Food and Drug Administration has given approval to its Anca-associated vasculitis therapy.

  • Shares of Allogene Therapeutics, Inc. ALLO plummeted 46.1% after the Food and Drug Administration put a hold on its cancer drug trials after chromosomal abnormality was detected in a single patient.

  • Shares of Walmart, Inc. WMT advanced 0.3% after the retailer announced it holiday season plans that include the launch of a direct-to-home wine delivery service.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Walmart Inc. (WMT) : Free Stock Analysis Report
 
ChemoCentryx, Inc. (CCXI) : Free Stock Analysis Report
 
Allogene Therapeutics, Inc. (ALLO) : Free Stock Analysis Report
 
Accolade, Inc. (ACCD) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research